Coronary Stents Market

Coronary Stents Market (Bare Metal Stents, Drug Eluting Stents and Bio-absorbable Stents) - Global Industry Analysis, Size, Share, Pipeline Overview, Growth, Trends and Forecast, 2013 - 2019

  • Rep Id : TMRGL23
  • Published On : May 2014
  • No. of Pages : 100
  • Category : Healthcare

Table of Content

 

Chapter 1 Introduction

1.1 Report Description

1.2 Market Segmentation

1.3 Research Methodology

 

Chapter 2 Executive Summary

2.1 Market Snapshot: Global Coronary Stents Market

2.2 Comparative Analysis: Global Coronary Stents Market, by Geography, 2012 & 2019 (Value %)

 

Chapter 3 Global Coronary Stents Market Overview

3.1 Introduction

3.2 Market Drivers

      3.2.1 Increasing Prevalence of Coronary Artery Diseases (CADs)

      3.2.2 Rise in Global Obesity Rates

      3.2.3 Aging Population

      3.2.4 Increasing Uptake of Technologically Advanced Coronary Stents like Bio-absorbable Stents

3.3 Market Restraints

      3.3.1 High Product Cost

      3.3.2 Lack of Efficient Reimbursement System

      3.3.3 High Risk of In-stent and Late-stent Restenosis and Thrombosis

3.4 Market Opportunities

      3.4.1 Novel Technologies in Clinical Trials will Address Various Unmet Needs of the Patient Pool

      3.4.2 High Growth Opportunities in the Emerging Markets of APAC, LATAM and Africa

3.5 Porter’s Five Forces Analysis: Global Coronary Stents Market

      3.5.1 Bargaining Power of Suppliers

      3.5.2 Bargaining Power of Buyers

      3.5.3 Threat of Substitutes

      3.5.4 Threat of New Entrants

      3.5.5 Competitive Rivalry

3.6 Market Attractiveness Analysis: Global Coronary Stents Market, by Geography

3.7 Competitive Landscape

      3.7.1 Market Share Analysis: Global Coronary Stents Market, 2012 (Value %)

 

Chapter 4 Global Coronary Stents Market, by Product Type

4.1 Overview

      4.1.1 Coronary Stents: Key Brands by Manufacturer

      4.1.2 Global Coronary Stents Market Revenue, by Product Type, 2011 – 2019 (USD Million)

      4.1.3 Comparative Analysis: Global Coronary Stents Market, by Product Type, 2012 & 2019 (Value %)

4.2 Bare Metal Stents

      4.2.1 Bare Metal Stents: Key Brands by Manufacturer

      4.2.2 Global Bare Metal Stents Market Revenue, 2011 – 2019 (USD Million)

4.3 Drug Eluting Stents

      4.3.1 Drug Eluting Stents: Key Brands by Manufacturer

      4.3.2 Global Drug Eluting Stents Market Revenue, 2011 – 2019 (USD Million)

4.4 Bio-absorbable Stents

      4.4.1 Bio-absorbable Stents: Key Brands by Manufacturer

      4.4.2 Global Bio-absorbable Stents Market Revenue, 2011 – 2019 (USD Million)

 

Chapter 5 Global Coronary Stents Market: Pipeline Overview

5.1 Overview

5.2 CORACTO

5.3 EXCELLA II and EXCELLA BD

5.4 DESolve Nx and DESolve FIM

5.5 ZoMaxx I and ZoMaxx II

5.6 ABSORB STEMI

5.7 BioFreedom

5.8 TAXUS PERSEUS

5.9 BioNIR

 

Chapter 6 Global Coronary Stents Market, by Geography

6.1 Overview

      6.1.1 Global Coronary Stents Market Revenue, by Geography, 2011 – 2019 (USD Million)

6.2 North America

      6.2.1 North America Coronary Stents Market Revenue, 2011 - 2019 (USD Million)

6.3 Europe

      6.3.1 Europe Coronary Stents Market Revenue, 2011 - 2019 (USD Million)

6.4 Asia-Pacific

      6.4.1 Asia-Pacific Coronary Stents Market Revenue, 2011 - 2019 (USD Million)

6.5 Rest of the World (RoW)

      6.5.1 RoW Coronary Stents Market Revenue, 2011 - 2019 (USD Million)

 

Chapter 7 Recommendations

7.1 Investing in Research and Development of Technologically Advanced Products with Additional Benefits

7.2 Targeting Emerging Markets such as India, China, Brazil, Mexico, Russia and South Africa

7.3 Emphasis on Price Control

 

Chapter 8 Company Profiles

8.1 Abbott Laboratories, Inc.

      8.1.1 Company Overview

      8.1.2 Financial Overview

      8.1.3 Product Portfolio

      8.1.4 Business Strategies

      8.1.5 Recent Developments

8.2 amg International GmbH

      8.2.1 Company Overview

      8.2.2 Financial Overview

      8.2.3 Product Portfolio

      8.2.4 Business Strategies

      8.2.5 Recent Developments

8.3 B. Braun Melsungen AG

      8.3.1 Company Overview

      8.3.2 Financial Overview      

      8.3.3 Product Portfolio

      8.3.4 Business Strategies

      8.3.5 Recent Developments

8.4 Biotronik SE & Co. KG

      8.4.1 Company Overview

      8.4.2 Financial Overview

      8.4.3 Product Portfolio

      8.4.4 Business Strategies

      8.4.5 Recent Developments

8.5 Boston Scientific Corporation

      8.5.1 Company Overview

      8.5.2 Financial Overview

      8.5.3 Product Portfolio

      8.5.4 Business Strategies

      8.5.5 Recent Developments

8.6 C. R. Bard, Inc.

      8.6.1 Company Overview

      8.6.2 Financial Overview

      8.6.3 Product Portfolio

      8.6.4 Business Strategies

      8.6.5 Recent Developments

8.7 Cook Medical, Inc.

      8.7.1 Company Overview

      8.7.2 Financial Overview

      8.7.3 Product Portfolio

      8.7.4 Business Strategies

      8.7.5 Recent Developments

8.8 Johnson & Johnson

      8.8.1 Company Overview

      8.8.2 Financial Overview

      8.8.3 Product Portfolio

      8.8.4 Business Strategies

      8.8.5 Recent Developments

8.9 Medtronic, Inc.

      8.9.1 Company Overview

      8.9.2 Financial Overview

      8.9.3 Product Portfolio

      8.9.4 Business Strategies

      8.9.5 Recent Developments

8.10 MicroPort Scientific Corporation

        8.10.1 Company Overview

        8.10.2 Financial Overview

        8.10.3 Product Portfolio

        8.10.4 Business Strategies 

        8.10.5 Recent Developments

8.11 STENTYS SA

        8.11.1 Company Overview

        8.11.2 Financial Overview

        8.11.3 Product Portfolio

        8.11.4 Business Strategies

        8.11.5 Recent Developments

8.12 Terumo Corporation

        8.12.1 Company Overview

        8.12.2 Financial Overview

        8.12.3 Product Portfolio

        8.12.4 Business Strategies

        8.12.5 Recent Developments

List of Tables

 

TABLE 1 Market Snapshot: Global Coronary Stents  Market

TABLE 2 Coronary Stents: Key Brands by Manufacturer

TABLE 3 Global Coronary Stents Market Revenue, by Product Type, 2011 – 2019 (USD Million)

TABLE 4 Bare Metal Stents: Key Brands by Manufacturer

TABLE 5 Drug Eluting Stents: Key Brands by Manufacturer

TABLE 6 Bio-absorbable Stents: Key Brands by Manufacturer

TABLE 7 Global Coronary Stents Market Revenue, by Geography, 2011 – 2019 (USD Million)

List of Figures

 

FIG. 1 Coronary Stents: Market Segmentation

FIG. 2 Global Coronary Stents Market, by Product Type, 2012 (USD Million)

FIG. 3 Comparative Analysis: Global Coronary Stents Market, by Geography, 2012 & 2019 (Value %)

FIG. 4 Porter’s Five Forces Analysis: Global Coronary Stents Market

FIG. 5 Market Attractiveness Analysis: Global Coronary Stents Market, by Geography

FIG. 6 Market Share by Key Players: Global Coronary Stents Market, 2012 (Value %)

FIG. 7 Comparative Analysis: Global Coronary Stents Market, by Product Type, 2012 & 2019 (Value %)

FIG. 8 Global Bare Metal Stents Market Revenue, 2011 – 2019 (USD Million)

FIG. 9 Global Drug Eluting Stents Market Revenue, 2011 – 2019 (USD Million)

FIG. 10 Global Bio-absorbable Stents Market Revenue, 2011 – 2019 (USD Million)

FIG. 11 North America Coronary Stents Market Revenue, 2011 – 2019 (USD Million)

FIG. 12 Europe  Coronary Stents Market Revenue, 2011 – 2019 (USD Million)

FIG. 13 Asia-Pacific Coronary Stents Market Revenue, 2011 – 2019 (USD Million)

FIG. 14 RoW Coronary Stents Market Revenue, 2011 – 2019 (USD Million)

FIG. 15 Abbott Laboratories, Inc.: Annual Revenue, 2010 – 2012 (USD Million)

FIG. 16 B. Braun Melsungen AG: Annual Revenue, 2010 – 2012 (USD Million)

FIG. 17 Boston Scientific Corporation: Annual Revenue, 2010 – 2012 (USD Million)

FIG. 18 C. R. Bard, Inc.: Annual Revenue, 2010 – 2012 (USD Million)

FIG. 19 Johnson & Johnson: Annual Revenue, 2010 – 2012 (USD Million)

FIG. 20 Medtronic, Inc.: Annual Revenue, 2010 - 2012 (USD Million)

FIG. 21 MicroPort Scientific Corporation: Annual Revenue, 2010 - 2012 (USD Million)

FIG. 22 STENTYS SA: Annual Revenue, 2010 – 2012 (USD Million)

FIG. 23 Terumo Corporation: Annual Revenue, 2010 – 2012 (USD Million)